Endocrine Abstracts

Contents

• CME Training Day Sessions
• • CME Symposium 1
  • • Recent advances in the management of pituitary adenomas

      ea0111cme1.1
    • An approach to endocrine late effects

      ea0111cme1.2
  • CME Symposium 2
  • • Abstract unavailable

      ea0111cme2.1
    • Abstract unavailable

      ea0111cme2.2
  • CME Symposium 3
  • • Abstract unavailable

      ea0111cme3.1
    • Abstract unavailable

      ea0111cme3.2
  • CME Symposium 4
  • • Abstract unavailable

      ea0111cme4.1
    • Talking to children and young people about sex development and gender identity

      ea0111cme4.2
• Plenary Lectures
• • Plenary
  • • Navigating the role of paediatric endocrinology in young people's gender services

      ea0111pl1
• Symposia
• • CEW Symposium
  • • Current and future pharmacological therapy in weight management

      ea0111cs1.1
    • Abstract unavailable

      ea0111cs1.2
    • Abstract unavailable

      ea0111cs1.3
  • Endocrine Symposium 1
  • • Screening 100,000 newborns using whole genome sequencing: the generation study

      ea0111es1.1
    • Abstract unavailable

      ea0111es1.2
    • Abstract unavailable

      ea0111es1.3
  • Endocrine Symposium 2 (Nurses/Endocrine Professionals Session)
  • • Abstract unavailable

      ea0111es2.1
    • Artificial intelligence: reimagining growth and pituitary management

      ea0111es2.2
    • Hypothalamic damage - grieving survival

      ea0111es2.3
  • Endocrine Symposium 3
  • • Abstract unavailable

      ea0111es3.1
    • Looking to the future - an oncologist's view of managing late effects

      ea0111es3.2
    • Abstract unavailable

      ea0111es3.3
  • Diabetes Symposium 1
  • • Abstract unavailable

      ea0111ds1.1
    • Genetic screening for type 1 diabetes and primary prevention studies from GPADD

      ea0111ds1.2
    • Abstract unavailable

      ea0111ds1.3
  • Diabetes Symposium 2
  • • The GIRFT programme for children and young adults' diabetes

      ea0111ds2.1
    • Abstract unavailable

      ea0111ds2.2
    • Grand challenge

      ea0111ds2.3
  • Diabetes Symposium 3
  • • Abstract unavailable

      ea0111ds3.1
    • Abstract unavailable

      ea0111ds3.2
    • Abstract unavailable

      ea0111ds3.3
• How Do I Sessions
• • How Do I Sessions
  • • Abstract unavailable

      ea0111hdi1.1
    • Abstract unavailable

      ea0111hdi1.2
• Debate
• • Debate
  • • Use of growth hormone in idiopathic short stature (For)

      ea0111d1.1
    • Debate: use of GH in idiopathic short stature (ISS). professors helen storr and Justin Davies

      ea0111d1.2
• Personal Practice Session
• • Personal Practice Session
  • • Abstract unavailable

      ea0111pps1
• Oral Communications
• • CME Case Presentations 1
  • • [ldquo]Hidden in plain sight[rdquo]: a mini-series of diagnostic difficulties in paediatric cushing's disease

      ea0111oc1.1
    • A rare case of papillary thyroid carcinoma in a child with a CDC73 mutation

      ea0111oc1.2
  • CME Case Presentations 2
  • • Hyperparathyroidism, pseudohypoparathyroidism (PHP) or pseudopseudohypoparathyroidism (PPHP) - solving the GNAS riddle

      ea0111oc2.1
    • A rare case of heterozygous INSR variant presenting as hyperandrogenism in adolescence

      ea0111oc2.2
  • CME Case Presentations 3
  • • Teenage kicks: the complexity of an adolescent living with diabetes. subcutaneous insulin resistance syndrome (SIRS) or a case of induced illness?

      ea0111oc3.1
    • A difficult diagnosis of B-all presenting with hypercalcaemia and multiple fractures

      ea0111oc3.2
  • CME Case Presentations 4
  • • Diagnostic and phenotypic challenges in a rare case of 46, XX differences in sex development (DSD) with a heterozygous RSPO1 variant

      ea0111oc4.1
  • Endocrine Oral Communications 1
  • • A novel polygenic risk prediction tool: improving the diagnosis of short stature

      ea0111oc5.1
    • Pilot data from the I-HH registry: improving management in hypogonadotropic hypogonadism

      ea0111oc5.2
    • Assessment of fetal growth trajectories and relationships with early infant adiposity at a single site within the uk pregnancies better eating and activity trial (UPBEAT)

      ea0111oc5.3
    • Disruption of the Wnt-antagonist APC in the pituitary stem cells is a driver of adamantinomatous craniopharyngioma

      ea0111oc5.4
    • Comparison of electronic growth chart software reveals clinically relevant variability hindering growth assessment: a UK study

      ea0111oc5.5
    • Practice patterns and treatment outcomes of growth-promoting therapies in CAH: insights from real-world data

      ea0111oc5.6
    • A multi-centre study of adrenal recovery in children tapering corticosteroids (ARCTiC study)

      ea0111oc5.7
    • The effect of letrozole on bone age maturation and estimated adult height in patients with congenital adrenal hyperplasia

      ea0111oc5.8
  • Endocrine Oral Communications 2
  • • Longitudinal evaluation of bone health index for assessment of bone health in duchenne muscular dystrophy

      ea0111oc6.1
    • Retrospective review of remission and relapse in paediatric graves' disease

      ea0111oc6.2
    • Evaluating fibroscan as a screening tool for metabolic dysfunction-associated steatotic liver disease in children and young people with obesity

      ea0111oc6.3
    • Systematic reassessment of children with congenital hypothyroidism in north west england through development of a multi-centre clinical network of paediatricians

      ea0111oc6.4
    • Boys with klinefelter syndrome referred to paediatric endocrine clinics have a much higher range of complexities than those in the community

      ea0111oc6.5
  • Diabetes Oral Communications 1
  • • Revealing metabolic clues through the use of continuous glucose monitoring

      ea0111oc7.1
    • A novel capillary-adjusted home oral glucose tolerance test: a practical and reliable alternative to the gold standard venous method in childhood early-stage type 1 diabetes

      ea0111oc7.2
    • A quality improvement innovation to improve the early diagnosis of type 1 diabetes in children and young people in wales: has it made an impact?

      ea0111oc7.3
    • Fast-tracking success: early hybrid closed loop initiation dramatically improves hba1c in the first year of care in CYP with type 1 diabetes

      ea0111oc7.4
    • Efficacy and safety of a tubeless AID system compared with MDI in children and adolescents with T1D in the RADIANT study

      ea0111oc7.5
  • Endocrine Oral Communications 3
  • • The use of medtech in empowering families within a complications of excess weight clinic: the evira® app

      ea0111oc8.1
    • Genotype-endocrine phenotype associations in a large cohort of children with NF1

      ea0111oc8.2
    • Quantification of 11-oxyandrogen biomarkers from dried blood spots using tandem mass spectrometry

      ea0111oc8.3
    • The IMPACT survey in the UK: treatment patterns in osteogenesis imperfecta

      ea0111oc8.4
    • Evaluating the predictive utility of basal cortisol for synacthen test outcomes in neonates: a retrospective cohort study

      ea0111oc8.5
  • Diabetes Oral Communications 2
  • • Developing a national schools training platform transforming diabetes awareness in schools across the uk to meet the needs highlighted in the 'The INSCHOOL' project

      ea0111oc9.1
    • Integrated, patient-centred, holistic transition model improves physical and psychosocial outcomes of young adults (16-25) with diabetes - transition safe and sound (TraSS), an NHS england pilot

      ea0111oc9.2
    • Reducing 'was not brought' rates in paediatric diabetes clinic: empowering patient choice to improve service delivery

      ea0111oc9.3
    • Quantifying the effect of screening for childhood type 1 diabetes on HbA1c, DKA and hospitalisation at diagnosis: a systematic review and meta-analysis

      ea0111oc9.4
    • Mind the gap: ongoing inequalities in glycaemic levels in young people living with type 1 diabetes across england and wales

      ea0111oc9.5
    • Analysing the impact of socioeconomic deprivation and ethnicity on the development of vascular complications in young people with type 1 diabetes - a regional perspective

      ea0111oc9.6
    • A phase ii, international, randomised, double-blind, efficacy and safety trial of sodium valproate in paediatric and adult patients with wolfram syndrome

      ea0111oc9.7
  • Endocrine Oral Communications 4
  • • Application of multi-omic approaches to investigate novel LZTR1 gene variants and identify therapeutic targets implicated in the pathogenesis of noonan syndrome (NS)

      ea0111oc10.1
    • Iatrogenic vitamin D toxicity within the paediatric population: an acute surge in national cases

      ea0111oc10.2
    • The united kingdom adult northstar network consensus recommendations of transition of osteoporosis care and management of osteoporosis in adults with duchenne muscular dystrophy

      ea0111oc10.3
    • Pubertal induction in girls with turner syndrome: updated retrospective data from the international TS registry

      ea0111oc10.4
    • Assessing the scale of the teenage obesity epidemic in northern ireland: an audit of prevalence and practice in the tertiary paediatric hospital

      ea0111oc10.5
    • [ldquo]Real world[rdquo] experience[rdquo] of treatment with wegovy (semagluatide) and saxenda (liragluatide) in a paediatric population living with severe obesity

      ea0111oc10.6
    • Citizens advice sheffield (CAS) and complications from excess weight (CEW) innovative integration pilot, recovering finances of over £29k for 31 families in initial 6 months

      ea0111oc10.7
    • Behind the glucose dip: a retrospective review of paediatric ketotic hypoglycaemia and evolving management approaches

      ea0111oc10.8
• Poster Presentations
• • Adrenal 1
  • • Cortisol responses to glucagon stimulation tests in children with short stature

      ea0111p1
    • Neonatal hypothermia and adrenal insufficiency: a case series of two presentations

      ea0111p2
    • Evaluating the indications for measuring cortisol in neonates, assessing frequency of short synacthen tests (SSTs) and identifying SST challenges and variations in newcastle, UK

      ea0111p3
    • Non-invasive biochemical monitoring for congenital adrenal hyperplasia (CAH) using 24-hour urinary steroid profiles

      ea0111p4
    • Parent perspectives to develop a symptom-tracker app to optimise home management of childhood adrenal insufficiency

      ea0111p5
    • Analysis of real-world data on the care provision of children with congenital adrenal hyperplasia in the United Kingdom and republic of Ireland

      ea0111p6
    • Establishing the current practice of the use of genetic testing for patients with congenital adrenal hyperplasia (CAH)

      ea0111p7
    • Care provision for patients with congenital adrenal hyperplasia: a scoping review to address gaps in research and patient care

      ea0111p8
    • 17[alpha]-Hydroxylase deficiency: from a rare presentation in infancy to transition to adult care

      ea0111p9
    • Cortisol response to hypoglycaemia in infants with congenital hyperinsulinism: a single centre retrospective cohort 2015-2025

      ea0111p10
  • Bone
  • • Bone mineral density and vertebral fractures in teenage and young adult patients with acute lymphoblastic leukaemia. a report from the british osteonecrosis study

      ea0111p11
    • ¹⁸Fluorocholine PET/CT scan in the investigation of a patient with persistent hypercalcaemia

      ea0111p12
    • Beyond the numbers: rare cause of persistent vitamin d deficiency in a child

      ea0111p13
    • Impact of body mass index on vertebral fracture risk and bone mineral density parameters in children with osteogenesis imperfecta

      ea0111p14
    • Long-term outcomes of intravenous zoledronate on DXA bone mineral content in duchenne muscular dystrophy

      ea0111p15
    • Hypercalcaemia as a sentinel sign of immunodeficiency: lessons from a case of infantile pneumocystis jirovecii pneumonia

      ea0111p16
    • Bone health in children with spinal muscular atrophy - a pilot study from a uk centre

      ea0111p17
    • Severe vitamin D deficiency in early infancy mimicking metabolic and genetic disorders: a case report

      ea0111p18
  • Diabetes 1
  • • Focussing on engagement provides an opportunity for equity of outcomes: no deterioration in glycaemic outcomes in young people aged 15 to 25 years

      ea0111p19
    • Reducing DNA rates and improving outcomes in a young person diabetes clinic: a quality improvement initiative

      ea0111p20
    • Socioeconomic disparities and their effect on hybrid closed-loop adherence and glycaemic outcomes in youth with type 1 diabetes

      ea0111p21
    • Improving asymptomatic screening rates for type 2 diabetes in at-risk children: a quality improvement project in a district general hospital

      ea0111p22
    • Using set basal rates for [ldquo]sick day rules[rdquo] in hybrid closed-loop therapy could result in insufficient insulin delivery

      ea0111p23
    • Prevalence of neurodevelopmental disorders (ASD/ADHD) in CYP with type 1 diabetes mellitus

      ea0111p25
    • Clinical characteristics and epidemiological patterns of initial presentation of diabetes mellitus in children and young people: a single-centre study in Sri Lanka

      ea0111p26
    • Hybrid closed-loop treatment technology implementation and evaluation on glycaemic outcomes in children and young people living with type 1 diabetes

      ea0111p27
    • Characterising type 2 diabetes in a multidisciplinary clinic: findings from a single-centre cohort

      ea0111p28
  • Diabetes 2
  • • Improvement in insulin sensitivity and glycaemic control in a type 1 diabetes patient following initiation of a GLP-1 receptor agonist for excess weight management

      ea0111p29
    • Impact of hybrid closed loop (HCL) systems on children and young people with type 1 diabetes

      ea0111p30
    • Symptomatic hypophosphatemia in a teenage girl with severe diabetic ketoacidosis

      ea0111p31
    • Type 2 diabetes in children and adolescents: presentation, treatment, and outcomes from a single-centre audit

      ea0111p32
    • Changing needs, user improvement suggestions and satisfaction with hybrid closed-loop insulin pump therapy

      ea0111p33
    • Optimising paediatric DKA management from emergency department to ward: integrating human factors through visual aids and competency tools

      ea0111p34
    • Integrating ultralong-acting insulin with HCL pumps in high-risk diabetes management: bridging the safety concern

      ea0111p35
    • Closing the loop on high HbA1c in paediatric type 1 diabetes with hybrid closed loop insulin pump therapy

      ea0111p36
    • Prevalence and risk factors for diabetic retinopathy in children with type 1 diabetes: an update from a single centre

      ea0111p37
    • Review of paediatric admissions of known diabetics in the belfast trust february 2023 - january 2025

      ea0111p38
  • Diabetes 3
  • • Evaluating the effectiveness of local network perioperative diabetes guidelines in great ormond street hospital (GOSH)

      ea0111p39
    • A novel non-autoimmune insulin-deficient diabetes subtype in a young child

      ea0111p40
    • Improving care for young people with type 2 diabetes in an ethnically diverse and socioeconomically deprived area of london: a local audit and pathway redesign

      ea0111p41
    • Bridging faith and care: ramadan fasting micro-teaching for muslim children and young people with type 1 diabetes

      ea0111p42
    • Assessing the impact of hybrid closed-loop systems on sleep in children with type 1 diabetes and their families at a tertiary diabetes centre in London

      ea0111p43
    • The adaptation of an eating disorder prevention intervention to a wales diabetes context: application of the ADAPT guidance to clinical context

      ea0111p44
    • From fluctuation to foundation: a case of ABCC8 neonatal diabetes underscoring the role of genetic diagnosis in personalized management

      ea0111p45
    • Evaluating inequalities in access to diabetes related technology at nottingham university hospitals (NUH)

      ea0111p46
    • Family perception of the process and challenges for their child/young person returning to school following a diagnosis of type 1 diabetes mellitus

      ea0111p47
    • Short term impact of a paediatric diabetes camp on glycaemic control- a service evaluation

      ea0111p48
  • Miscellaneous/Other 1
  • • Hypercalcaemia: a rare cause to consider

      ea0111p49
    • A single centre experience in paediatric cases of pheochromocytomas and paragangliomas

      ea0111p50
    • A national survey of paediatric turner syndrome services in the united kingdom: current practice and variability in care

      ea0111p51
    • Taming the cortisol storm: a paediatric case series on cushing's syndrome diagnostic challenges and management

      ea0111p52
    • Uptake and patient perception of tumour surveillance in a paediatric population with SDHx variants in a single-centre family clinic

      ea0111p53
    • To induce or not to induce - that is the question. delayed puberty in a male with anorexia and ARFID - a case report and literature review

      ea0111p54
    • Hypoparathyroidism as first manifestation of kearns-sayre syndrome (KSS)

      ea0111p55
    • Immunotherapy related neurotoxicity presenting as late-onset hypophysitis in an adolescent female with B-cell acute lymphoblastic leukaemia

      ea0111p56
    • Review of nottingham university hospitals' clinical practice for the screening of endocrinopathies in children receiving blood transfusions for sickle cell disease/rare anaemias

      ea0111p57
  • Obesity 1
  • • Social prescribing and complications of excess weight (CEW) clinics

      ea0111p58
    • [ldquo]I brush my teeth once a month[rdquo]: a service evaluation of dental team led oral health advice alongside complications from excess weight (CEW) clinics

      ea0111p59
    • Glucagon-like peptide-1 receptor agonists in paediatric hypothalamic obesity-single center experience

      ea0111p60
    • Survey on impact of childhood obesity on child health services in Wessex

      ea0111p61
    • Efficacy of tirzepatide in an adolescent with alstrom syndrome

      ea0111p62
    • Teen cooking for health (TECH): nutrition workshops for adolescents living with obesity

      ea0111p63
    • National evaluation of 39 complications of excess weight (CEW) clinics: exploring how innovation in design has been determined by individual and population health inequities

      ea0111p64
    • The complexity of patients referred to a complications of excessive weight service

      ea0111p65
  • Pituitary and Growth
  • • After the last inch: rethinking growth hormone therapy beyond final height

      ea0111p66
    • Height velocity and final height in a cohort of children born small for gestational age and treated with growth hormone

      ea0111p67
    • Beware the possibility of false normal results when testing for growth hormone deficiency

      ea0111p68
    • BMI trajectories in idiopathic central precocious puberty during GnRHa therapy: who is most at risk?

      ea0111p69
    • Inconsistent availability and functionality of electronic growth charts across the United Kingdom

      ea0111p70
    • Growth hormone stimulation testing in a tertiary paediatric hospital: a review of practice

      ea0111p71
    • The association between parental height and child stature: influencing socioeconomic factors in turkish primary school children living in urban area

      ea0111p72
    • Final height in seven children treated with recombinant IGF-1 for severe primary IGF-1 deficiency

      ea0111p73
    • Looking beyond the thyroid - a clinical case

      ea0111p74
    • GloBE-reg: an international registry platform for long-term evaluation of growth hormone therapy in children and adults

      ea0111p75
  • Adrenal 2
  • • Phenotypic heterogeneity and clinical implications of paediatric phaeochromocytoma: two case narratives

      ea0111p76
    • Assessing effects of low dose prophylactic hydrocortisone on hypothalamic-pituitary-adrenal axis in preterm infants: systematic review

      ea0111p77
    • Urinary steroid metabolomics, body composition and metabolic risk in children with premature adrenarche

      ea0111p78
    • A rare case of adrenal insufficiency associated with allgrove syndrome

      ea0111p79
    • Adrenal complications in paediatric patients living with spinal muscular atrophy - a single centre retrospective study

      ea0111p80
    • Real-world stability of salivary cortisol and cortisone samples

      ea0111p81
    • Iatrogenic adrenal suppression in children: how 'stressed' should paediatricians be?

      ea0111p82
    • National survey of current UK practice for the assessment of neonatal adrenal function

      ea0111p83
    • Predictive value of early morning cortisol levels in diagnosing adrenal insufficiency: a retrospective audit

      ea0111p84
  • Diabetes 4
  • • Disaster response and diabetes: rebuilding support systems for children and young people with type 1 diabetes post-earthquake in myanmar 2025

      ea0111p85
    • Barriers and facilitators in transitioning to multiple daily insulin in a resource limited setting: a qualitative study of laotian children and young people with T1D

      ea0111p86
    • ADNAT- a digital health assessment app for enhancing diabetes care and wellbeing in children and young people

      ea0111p87
    • Evaluating inequalities in the use of diabetes-related technology in children and young people from a black, asian and minority ethnic background in nottingham children's hospital

      ea0111p88
    • A regional 12-month project to evaluate diabetic ketoacidosis (DKA) presentations at diagnosis of type 1 diabetes

      ea0111p89
    • Reduction of high HbA1c in children and young people with type 1 diabetes mellitus through implementation of a 'high HbA1c pathway'

      ea0111p90
    • Diabetes mellitus characteristics in an international trial cohort with wolfram syndrome

      ea0111p91
    • Audit of national first year of care (FYOC) pathway for children and young people (CYP) with a new diagnosis of type 1 diabetes in england

      ea0111p92
    • The impact of proactive introduction of hybrid closed loop pump therapy on glycaemic control and reduction in inequity of tech uptake

      ea0111p93
    • Smart solutions for advancing diabetes education to schools

      ea0111p94
  • Diabetes 5
  • • A patient with mauriac syndrome - a rare complication of poor compliance with T1DM management

      ea0111p95
    • Highlighting differences in management between paediatric and adult services for 16-19 year olds with type 1 diabetes at guys and st thomas foundation trust

      ea0111p96
    • Real-world performance of the omnipod® 5 automated insulin delivery (AID) system in children and adolescents with type 1 diabetes in the united kingdom

      ea0111p97
    • Adjunctive glucose-lowering agents in children with type 1 diabetes: a systematic review and meta-analysis

      ea0111p98
    • Semaglutide as an add-on treatment to optimise glycaemic control in children and young people with type 1 diabetes (smile T1D trial) development and protocol

      ea0111p99
    • Improving the transition service and transfer process in Leeds

      ea0111p100
    • Culturally tailored digital resources for children and young adults with type 2 diabetes to promote safe medication use on young type 2 website and app

      ea0111p101
    • Actual automode use offers superior discrimination of HbA1c outcomes compared to relative automode use in children with type 1 diabetes using AID systems

      ea0111p102
    • Is advanced paediatric diabetes technology accessible to all? - a quality improvement project at the children's hospital for wales

      ea0111p103
    • The seamless diabetes transition (SDT) programme across yorkshire and humber: enhancing transition care for young people with diabetes

      ea0111p104
  • Diabetes 6
  • • Development of a national first year of care (FYOC) pathway for children and young people (CYP) with T2 diabetes (T2D) to improve care and outcomes

      ea0111p105
    • STID - sport and T1D: a pilot clinic

      ea0111p106
    • Improving care for children and young people (CYP) with type 2 diabetes: a guideline evaluation

      ea0111p107
    • Psychosocial factors are associated with poor glycaemic control in a type 1 diabetes mellitus (T1DM) paediatric cohort

      ea0111p108
    • Improving out-of-hours troubleshooting in paediatric type 1 diabetes: a quality improvement initiative

      ea0111p109
    • Audit of a multidisciplinary annual review clinic for children and young people with diabetes mellitus

      ea0111p110
    • Enhancing HbA1c outcomes through integrated collaboration within and between diabetes MDTs and families

      ea0111p111
    • How is paediatric type 1 diabetes treatment and glucose control impacted by safeguarding concerns?

      ea0111p112
    • Improving care for children at risk of steroid-induced hyperglycaemia: integrating proactive monitoring into routine hospital care

      ea0111p113
    • Factors contributing to late diagnosis of patients with type 1 diabetes mellitus: a retrospective audit at bedford hospital

      ea0111p114
  • Gonadal, DSD and Reproduction
  • • Blood chimerism in asymptomatic co twins: two paediatric cases highlighting genotype-phenotype discordance

      ea0111p115
    • Anthropometric benchmarks of care in congenital adrenal hyperplasia (ABC-CAH): initial results from an international, multi-centre registry benchmarking exercise

      ea0111p116
    • Puberty induction with gonadotropin treatment in males with hypogonadotropic hypogonadism: the ping study

      ea0111p117
    • An audit of clinical practice for girls with turner syndrome in nhs lothian, scotland

      ea0111p118
    • A service evaluation of the current management of children and adolescents with klinefelter syndrome across south and west wales

      ea0111p119
    • Beyond the obvious: WT1 mutation in a newborn with ambiguous genitalia

      ea0111p120
    • Outcomes of surgery in females with congenital adrenal hyperplasia - a scoping review of the literature

      ea0111p121
    • Isolated premature menarche: is there an increasing trend- a case series

      ea0111p122
    • Complete gonadal dysgenesis in a 46, XY individual associated with a pathogenic MAP3K1 variant: a case report and review of management

      ea0111p123
  • Miscellaneous/Other 2
  • • Improving CEW service awareness and obesity management in a district general hospital (DGH): an educational and quality improvement initiative

      ea0111p124
    • Swinging variability in diazoxide responsiveness in congenital hyperinsulinism due to pathogenic HNF4A variants: the role of continuous glucose monitoring

      ea0111p125
    • Digital poverty - barriers to care: a departmental experience

      ea0111p126
    • Diagnosis and management of congenital hyperinsulinism at a tertiary neonatal unit: a service review

      ea0111p127
    • Growth in children with Septo-optic dysplasia (SOD) treated with GnRH agonist therapy (GnRHa)

      ea0111p128
    • Active management of endocrine waiting lists by clinical triage

      ea0111p129
    • A rare case of polyurea in infancy

      ea0111p130
    • Hyperinsulinism in a child with an insulin gene variant. causative or co-INS-idence?

      ea0111p131
    • Challenging investigations in the diagnostic workup: a clinical perspective

      ea0111p132
  • Miscellaneous/Other 3
  • • From prematurity and adrenal insufficiency to a syndromic diagnosis: a rare case of MIRAGE syndrome

      ea0111p133
    • Perseverance in looking beyond the primary diagnosis; addison's disease and dent disease - an unlikely combination

      ea0111p134
    • Development and implementation of a CNS-led pathway to discontinue diazoxide at home in infants with transient hyperinsulinism

      ea0111p135
    • Transition of patients with congenital hyperinsulinism from proglycem® diazoxide liquid to diazoxide tablets

      ea0111p136
    • Abstract unavailable

      ea0111p137
    • Raising awareness of hyperinsulinism: empowering healthcare professionals in the early detection of a rare disease

      ea0111p138
    • Implementation of a digital perioperative planning interface in electronic patient records: a clinical audit in high-risk paediatric patients

      ea0111p139
    • Severe hypercalcaemia presenting with acute abdominal pain: learning from two cases of primary hyperparathyroidism

      ea0111p140
  • Obesity 2
  • • Inpatient stay to improve and sustain weight outcomes as part of holistic weight management strategy in Tier 3 children's obesity service

      ea0111p141
    • Weight trajectory in children and young people from referral to first appointment in a Tier 3 weight management clinic- impact of age, gender and IMD

      ea0111p142
    • Clinical outcomes of GLP-1 receptor agonist therapy in paediatric patients in the thames valley: a retrospective audit

      ea0111p143
    • What are the components and outcomes of multidisciplinary weight management interventions for children with obesity? a systematic review

      ea0111p144
    • Does social care involvement in children and adolescents living with obesity influence weight loss and BMI?

      ea0111p145
    • Group based weight management programmes in young people living with excess weight, do they work? an initial review

      ea0111p146
    • OGTT testing in paediatric obesity: can fasting glucose and HbA1c guide us?

      ea0111p147
  • Thyroid
  • • Congenital hypothyroidism with thyroid dyshormonogenesis- a case report

      ea0111p148
    • Time for standardised universal reference range for thyroid function test (TFTs): A study of impact of inter-laboratory variation in TFT results on clinical decision making

      ea0111p149
    • Case report: an autonomously functioning thyroid nodule in a 13-year-old

      ea0111p150